The murine intravaginal HSV-2 challenge model for investigation of DNA vaccines

Methods in Molecular Biology

Volumn 1144, Issue , 2014, Pages 305-327

  Marshak, Joshua O ^a   Dong, Lichun ^a   Koelle, David M ^a  

^a NONE

Author keywords

Animal model; Antibody; DNA vaccine; Dorsal root ganglia; Herpes simplex virus; Latency; Polymerase chain reaction

Indexed keywords

DNA VACCINE; HERPES SIMPLEX VACCINE; PROGESTERONE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DNA IMMUNIZATION; EXTERNAL EAR; FEMALE; GENE DOSAGE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; INNATE IMMUNITY; LAMINECTOMY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RECTUS FEMORIS MUSCLE; ANIMAL; DISEASE MODEL; GENETICS; GUINEA PIG; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR BIOLOGY; PROCEDURES;

ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; GUINEA PIGS; HERPESVIRUS 2, HUMAN; HUMANS; MICE; MOLECULAR BIOLOGY; PROGESTERONE; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 84919436770     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0428-0_21     Document Type: Article

References (35)

1. Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, Corey L, Wald A (2011) Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 305:1441-1449
2. Kask AS, Chen X, Marshak JO, Dong L, Saracino M, Chen D, Jarrahian C, Kendall MA, Koelle DM (2010) DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge. Vaccine 28:7483-7491
3. Feldman LT, Ellison AR, Voytek CC, Yang L, Krause P, Margolis TP (2002) Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A 99:978-983
4. Freeman ML, Sheridan BS, Bonneau RH, Hendricks RL (2007) Psychological stress compromises CD8+ T cell control of latent herpes simplex virus type 1 infections. J Immunol 179:322-328
5. Johnston C, Koelle DM, Wald A (2011) HSV- 2: in pursuit of a vaccine. J Clin Invest 121:4600-4609
6. Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, Parr EL (1994) A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest 70:369-380
7. Linehan MM, Richman S, Krummenacher C, Eisenberg RJ, Cohen GH, Iwasaki A (2004) In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa. J Virol 78:2530-2536
8. Cherpes TL, Busch JL, Sheridan BS, Harvey SA, Hendricks RL (2008) Medroxyprogesterone acetate inhibits CD8+ T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation. J Immunol 181:969-975
9. Lopez C (1975) Genetics of natural resistance to herpes virus infections in mice. Nature 258:1352-1353
10. St Leger AJ, Peters B, Sidney J, Sette A, Hendricks RL (2011) Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice. J Immunol 186:3927-3933
11. Gebhardt T, Whitney PG, Zaid A, Mackay LK, Brooks AG, Heath WR, Carbone FR, Mueller SN (2011) Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature 477:216-219
12. Muller WJ, Dong L, Vilalta A, Byrd B, Wilhelm KM, McClurkan CL, Margalith M, Liu C, Kaslow D, Sidney J, Sette A, Koelle DM (2009) Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection. J Gen Virol 90:1153-1163
13. Shlapobersky M, Marshak JO, Dong L, Huang ML, Wei Q, Chu A, Rolland A, Sullivan S, Koelle DM (2012) Vaxfectin adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection. J Gen Virol 93:1305-1315
14. Sin JI, Kim JJ, Zhang D, Weiner DB (2001) Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen- specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo. Hum Gene Ther 12:1091-1102
15. Chen X, Kask AS, Crichton ML, McNeilly C, Yukiko S, Dong L, Marshak JO, Jarrahian C, Fernando GJ, Chen D, Koelle DM, Kendall MA (2010) Improved DNA vaccination by skin-targeted delivery using dry-coated denselypacked microprojection arrays. J Control Release 148(3):327-333
16. Glenting J, Wessels S (2005) Ensuring safety of DNA vaccines. Microb Cell Fact 4:26
17. Dutton J, Li B, Woo W-P, Marshak K, Xu Y, Huang ML, Dong L, Frazer I, Koelle D (2012) Protection against viral challenge in a murine model of HSV-2 infection conferred by mixed DNA vaccines. Presented at 37th International Herpesvirus Workshop, Calgary, Alberta, Canada
18. Liu W, Gao F, Zhao KN, Zhao W, Fernando GJ, Thomas R, Frazer IH (2002) Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology 301:43-52
19. Everett RD, Fenwick ML (1990) Comparative DNA sequence analysis of the host shutoff genes of different strains of herpes simplex virus: type 2 strain HG52 encodes a truncated UL41 product. J Gen Virol 71(Pt 6):1387-1390
20. Dudek TE, Torres-Lopez E, Crumpacker C, Knipe DM (2011) Evidence for differences in immunologic and pathogenesis properties of herpes simplex virus 2 strains from the United States and South Africa. J Infect Dis 203: 1434-1441
21. Stanberry LR, Kit S, Myers MG (1985) Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs. J Virol 55:322-328
22. Nakanishi Y, Lu B, Gerard C, Iwasaki A (2009) CD8(+) T lymphocyte mobilization to virus infected tissue requires CD4(+) T-cell help. Nature 462:510-513
23. Halford WP, Puschel R, Gershburg E, Wilber A, Gershburg S, Rakowski B (2011) A liveattenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine. PLoS One 6:e17748
24. Magaret AS, Wald A, Huang ML, Selke S, Corey L (2007) Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa. J Clin Microbiol 45:1618-1620
25. McClements WL, Armstrong ME, Keys RD, Liu MA (1996) Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc Natl Acad Sci U S A 93:11414-11420
26. Belshe RB, Leone PA, Bernstein DI, Wald A, Levin MJ, Stapleton JT, Gorfinkel I, Morrow RL, Ewell MG, Stokes-Riner A, Dubin G, Heineman TC, Schulte JM, Deal CD (2012) Effi cacy results of a trial of a herpes simplex vaccine. N Engl J Med 366:34-43
27. Cattamanchi A, Posavad CM, Wald A, Baine Y, Moses J, Higgins TJ, Ginsberg R, Ciccarelli R, Corey L, Koelle DM (2008) Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2- seronegative adults by a needle-free injection system. Clin Vaccine Immunol 15:1638-1643
28. Marshak JO, Kask A, Dong L, Koelle MD (2014) University of Washington
29. Lekstrom-Himes JA, Pesnicak L, Straus SE (1998) The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks. J Virol 72:2760-2764
30. Khanna KM, Bonneau RH, Kinchington PR, Hendricks RL (2003) Herpes simplex virus specific memory CD8(+) T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18:593-603
31. Herbst-Kralovetz MM, Pyles RB (2006) Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection. J Virol 80:9988-9997
32. Strasser JE, Arnold RL, Pachuk C, Higgins TJ, Bernstein DI (2000) Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein D plasmid constructs. J Infect Dis 182: 1304-1310
33. Koelle DM (2003) Expression cloning for the discovery of viral antigens and epitopes recognized by T-cells. Methods 29:213-226
34. Laing KJ, Dong L, Sidney J, Sette A, Koelle DM (2012) Immunology in the clinic review series; focus on host responses: T cell responses to herpes simplex viruses. Clin Exp Immunol 167:47-58
35. Malin SA, Davis BM, Molliver DC (2007) Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity. Nat Protoc 2:152-160